Business Context and Reporting Period
Company: iQSTEL Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 14, 2025
Event: Entry into a Material Definitive Agreement involving a Common Stock Purchase Option and Registration Rights Agreement with ADI Funding LLC.
Key Financial Metrics
This filing does not report standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a new financing agreement.
- Option Consideration: $100,000 paid for the right to acquire shares.
- Option Size: Up to 15,000,000 shares of common stock.
- Expiration Date: July 14, 2025.
- Exercise Price: 70% of the Volume Weighted Average Price (VWAP) of the 10 trading days preceding exercise, subject to a floor of $0.11 per share.
- Beneficial Ownership Limit: 4.99% (increasable to 9.99% upon notice).
Material Changes
The filing discloses the execution of a Stock Purchase Agreement and a Registration Rights Agreement with ADI Funding LLC. Key terms include:
- Mandatory Exercise: ADI Funding is obligated to exercise the option for at least 2,000,000 shares within 15 days of an effective registration statement.
- Subsequent Exercises: Additional exercises must be in increments of at least 1,000,000 shares on a cash basis.
- Anti-Dilution: If the company issues securities at a price lower than the option exercise price, ADI Funding has the right to use that lower price for its option exercises.
- Registration Rights: The company agreed to register the resale of shares underlying the option with the SEC.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, outlook, or management commentary regarding future operations or financial performance.
Risks and Contingencies:
- Dilution Risk: The agreement allows for the issuance of up to 15,000,000 shares, which may significantly dilute existing shareholders depending on the exercise price and timing.
- Market Price Dependency: The exercise price is tied to the VWAP, introducing variability based on market conditions.
- Registration Timing: The mandatory exercise of 2,000,000 shares is contingent upon the effectiveness of a registration statement.
Investor Verification Checklist
- Verify the current number of outstanding common shares to assess the potential dilution impact of the 15,000,000 share option.
- Review the attached Exhibits 4.1, 10.1, and 10.2 for complete legal terms not summarized in the 8-K.
- Monitor the status of the registration statement required to trigger the mandatory 2,000,000 share exercise.
- Check recent trading volume and price history to estimate the potential exercise price (70% of 10-day VWAP).
- Confirm if the company has issued any securities at a price below $0.11 since the agreement date, which would trigger the anti-dilution provision.